These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22292477)

  • 1. Blockage of the afferent sensitive pathway prevents sympathetic atrophy and hemodynamic alterations in rat portal hypertension.
    Ezkurdia N; Coll M; Raurell I; Rodriguez S; Cuenca S; González A; Guardia J; Esteban R; Genescà J; Martell M
    Liver Int; 2012 Sep; 32(8):1295-305. PubMed ID: 22292477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
    Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neuronal apoptosis and axonal regression ameliorates sympathetic atrophy and hemodynamic alterations in portal hypertensive rats.
    Ezkurdia N; Raurell I; Rodríguez S; González A; Esteban R; Genescà J; Martell M
    PLoS One; 2014; 9(1):e84374. PubMed ID: 24400086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
    Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
    J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central neural activation of hyperdynamic circulation in portal hypertensive rats depends on vagal afferent nerves.
    Liu H; Schuelert N; McDougall JJ; Lee SS
    Gut; 2008 Jul; 57(7):966-73. PubMed ID: 18270244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperdynamic mesenteric circulation in cirrhosis: humoral or neural mechanism?
    Alhassan N; Liu H
    Liver Int; 2012 Sep; 32(8):1191-3. PubMed ID: 22882588
    [No Abstract]   [Full Text] [Related]  

  • 10. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats.
    Fernández M; Casadevall M; Schuligoi R; Pizcueta P; Panés J; Barrachina MD; Donnerer J; Piqué JM; Esplugues JV; Bosch J
    Hepatology; 1994 Dec; 20(6):1609-14. PubMed ID: 7982662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
    Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
    Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension.
    Moleda L; Jurzik L; Froh M; Gäbele E; Hellerbrand C; Straub RH; Schölmerich J; Wiest R
    World J Gastroenterol; 2010 Apr; 16(15):1837-44. PubMed ID: 20397260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?
    Møller S; Stauber RE
    Liver Int; 2010 Apr; 30(4):499-501. PubMed ID: 20158609
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcitonin gene-related peptide and spinal afferents partly mediate postoperative colonic ileus in the rat.
    Zittel TT; Lloyd KC; Rothenhöfer I; Wong H; Walsh JH; Raybould HE
    Surgery; 1998 May; 123(5):518-27. PubMed ID: 9591004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
    Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
    Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disordered central cardiovascular regulation in portal hypertensive and cirrhotic rats.
    Song D; Sharkey KA; Breitman DR; Zhang Y; Lee SS
    Am J Physiol Gastrointest Liver Physiol; 2001 Mar; 280(3):G420-30. PubMed ID: 11171624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.